This company is so hard to pick. I've wanted to buy in for a while but something keeps telling me to wait.Its a hard one to follow although had I see it at 21 I probably would have jumped in.I'll keep watching.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ASX Market Open: Rising Aussie markets to ignore Wall Street's Thanksgiving caution | November 28, 2024